“Efficacy of Deucravacitinib over time in Psoriasis by Baseline Total Body Surface Area: Post Hoc Analysis of the Randomized, Double-blind, Placebo-controlled Phase 3b/4 PSORIATYK SCALP Trial” (2025) SKIN The Journal of Cutaneous Medicine, 9(2), p. s537. doi:10.25251/skin.10.supp.537.